Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic comparison of oral P2Y12 loading strategies transitioning from cangrelor in PCI
DRKS00009739Phase 3Completed
- Sponsor
- Universitäts-Herzzentrum Freiburg-Bad Krozingen
- Start
- Jan 2016
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Chronic Coronary Syndrome (CCS) and coronary arteriosclerosis comparing Cangrelor + prasugrel loading, Cangrelor + ticagrelor loading and Cangrelor + clopidogrel loading after infusion (3 arms). Primary endpoint: Pharmacodynamic comparison of oral P2Y12 loading strategies during transition from cangrelor. Started Jan 2016; status: completed.
02
Drugs
cangrelorprasugrelticagrelorclopidogrel
03
Conditions
Chronic Coronary Syndrome (CCS)coronary arteriosclerosis
Beyond the preview
Go deeper on DRKS00009739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00009739.